These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 22810435

  • 21. Intraaortic balloon support for myocardial infarction with cardiogenic shock.
    Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K, IABP-SHOCK II Trial Investigators.
    N Engl J Med; 2012 Oct 04; 367(14):1287-96. PubMed ID: 22920912
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U.
    Am Heart J; 2012 Jun 04; 163(6):938-45. PubMed ID: 22709745
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
    Andrié RP, Becher UM, Frommold R, Tiyerili V, Schrickel JW, Nickenig G, Schwab JO.
    Crit Care; 2012 Aug 13; 16(4):R152. PubMed ID: 22889197
    [Abstract] [Full Text] [Related]

  • 28. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A.
    EuroIntervention; 2011 Aug 13; 7(4):437-41. PubMed ID: 21764661
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization.
    Mao CT, Wang JL, Chen DY, Tsai ML, Lin YS, Cherng WJ, Wang CH, Wen MS, Hsieh IC, Hung MJ, Chen CC, Chen TH.
    PLoS One; 2016 Aug 13; 11(8):e0160070. PubMed ID: 27483439
    [Abstract] [Full Text] [Related]

  • 31. Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial.
    de Waha S, Schoene K, Fuernau G, Desch S, Eitel I, Pöss J, Meyer-Saraei R, Eitel C, Tilz R, Schuler G, Werdan K, Schneider S, Ouarrak T, Zeymer U, Thiele H.
    Clin Res Cardiol; 2018 Mar 13; 107(3):233-240. PubMed ID: 29127472
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selenoprotein P in Myocardial Infarction With Cardiogenic Shock.
    Büttner P, Obradovic D, Wunderlich S, Feistritzer HJ, Holzwirth E, Lauten P, Fuernau G, de Waha-Thiele S, Desch S, Thiele H.
    Shock; 2020 Jan 13; 53(1):58-62. PubMed ID: 30889044
    [Abstract] [Full Text] [Related]

  • 34. [Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock].
    Guo C, Teng HB, Zhang J, Li J, Xu HB, Wang XY, Yuan JS, Yang WX, Hu FH, Wu Y, Qiao SB.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug 24; 48(8):675-681. PubMed ID: 32847324
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.
    Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR, Gibson CM, Hochman JS, Ohman EM, Cheeks M, Barron HV, Investigators in the National Registry of Myocardial Infarction 2.
    Circulation; 2003 Aug 26; 108(8):951-7. PubMed ID: 12912817
    [Abstract] [Full Text] [Related]

  • 37. Shenfu Injection () inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock.
    Jin YY, Gao H, Zhang XY, Ai H, Zhu XL, Wang J.
    Chin J Integr Med; 2017 Mar 26; 23(3):170-175. PubMed ID: 28028723
    [Abstract] [Full Text] [Related]

  • 38. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
    Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP.
    J Am Coll Cardiol; 2017 Jan 24; 69(3):278-287. PubMed ID: 27810347
    [Abstract] [Full Text] [Related]

  • 39. Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.
    Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J, Gitt A, Zahn R.
    Clin Res Cardiol; 2013 Mar 24; 102(3):223-7. PubMed ID: 23179136
    [Abstract] [Full Text] [Related]

  • 40. Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry.
    Kim BS, Jang WJ, Choi KH, Kim SH, Yu CW, Jeong JO, Lee HJ, Gwon HC, Kim HJ, Yang JH.
    Medicina (Kaunas); 2024 Jan 20; 60(1):. PubMed ID: 38276062
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.